Related Experiment Video
Updated: Mar 28, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.6K
Current and emerging treatments for severe asthma.
Khalid Al Efraij1, J Mark FitzGerald1
1University of British Columbia, Faculty of Medicine, Division of Respirology, 2775 Laurel St, Vancouver, BC V5Z 1M9, Canada.
Journal of Thoracic Disease
|December 31, 2015
Summary
Severe asthma affects a small percentage of patients but incurs high costs. Novel therapies like tiotropium, omalizumab, mepolizumab, and thermoplasty offer improved asthma control and reduce exacerbations in selected individuals.
Area of Science:
- Pulmonology
- Allergy and Immunology
- Pharmacology
Background:
- Severe asthma represents 5% of cases but causes 50% of economic burden.
- Standard therapies and factor elimination often fail to control severe asthma.
- Significant unmet need exists for effective severe asthma treatments.
Purpose of the Study:
- To evaluate novel therapeutic options for severe asthma.
- To assess the efficacy of new treatments in improving asthma control.
- To determine the impact of novel therapies on asthma exacerbations.
Main Methods:
- Review of current literature on severe asthma management.
- Analysis of data on tiotropium, omalizumab, mepolizumab, and thermoplasty.
- Focus on treatment in well-selected patient populations.
Main Results:
- Novel therapies demonstrate improved asthma control.
- Significant reduction in asthma exacerbations observed.
- Tiotropium, omalizumab, mepolizumab, and thermoplasty are effective in specific patient groups.
Conclusions:
- New treatments address the unmet needs in severe asthma.
- Targeted use of these therapies enhances patient outcomes.
- These advancements offer better management for difficult-to-treat asthma.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
01:30Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
2.0K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
2.0K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.5K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.5K
01:20Asthma: Pathogenesis and Management
1.7K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
01:23Inhaled Medications
987
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
987